Randomized Embolization Trial for NeuroEndocrine Tumor Metastases To The Liver
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 12
Summary
- Conditions
- Liver Metastases
- Neuroendocrine Tumor, Malignant
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT02724540
- Collaborators
- Guerbet
- Investigators
- Principal Investigator: Michael C Soulen, MD, FSIR University of Pennsylvania
Get Well Soon